Twinstrand is a private clinical-stage biopharmaceutical company dedicated to the discovery and development of biological drugs for the treatment of life-threatening diseases. Its pipeline includes products with applications in cancer; viral, parasitic and fungal diseases; and biodefence. (Acquired by Cangene, now Emergent Biosolutions)